The collaboration aims to develop new medicines to reduce chronic kidney disease in Scotland
Category: astrazeneca
NSCLC accounts for around 85% of all lung cancer cases, particularly in non-smoking patients
The partnership will provide six MRC clinical fellows with industry placement opportunities
Up to 20% of prostate cancer cases are classified as castration-resistant